David Reynoso

465 total citations
9 papers, 372 citations indexed

About

David Reynoso is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, David Reynoso has authored 9 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Gastroenterology and 2 papers in Surgery. Recurrent topics in David Reynoso's work include Gastrointestinal Tumor Research and Treatment (7 papers), Sarcoma Diagnosis and Treatment (6 papers) and Gastric Cancer Management and Outcomes (3 papers). David Reynoso is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (7 papers), Sarcoma Diagnosis and Treatment (6 papers) and Gastric Cancer Management and Outcomes (3 papers). David Reynoso collaborates with scholars based in United States, France and Belgium. David Reynoso's co-authors include Jonathan C. Trent, Alexander J. Lazar, Wei‐Lien Wang, Srirupa Roy, John C. McAuliffe, Anu Gupta, Takahiro Taguchi, James T. McMahon, Maria Dêbiec‐Rychter and Jayanta Debnath and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Cancer Research and Carcinogenesis.

In The Last Decade

David Reynoso

8 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Reynoso United States 8 155 135 110 104 81 9 372
Qirong Geng China 12 158 1.0× 172 1.3× 35 0.3× 56 0.5× 112 1.4× 27 469
Yasunori Deguchi Japan 10 160 1.0× 104 0.8× 34 0.3× 49 0.5× 153 1.9× 16 352
Yemarshet K. Gebreyohannes Belgium 11 185 1.2× 86 0.6× 131 1.2× 17 0.2× 105 1.3× 22 322
Stefan Paul Moenig Germany 9 102 0.7× 90 0.7× 24 0.2× 34 0.3× 143 1.8× 21 300
Jung Shin Lee South Korea 10 321 2.1× 73 0.5× 49 0.4× 98 0.9× 313 3.9× 18 477
Meiling Zhu China 14 156 1.0× 199 1.5× 28 0.3× 25 0.2× 137 1.7× 25 410
Ho Young Lim South Korea 8 163 1.1× 134 1.0× 44 0.4× 41 0.4× 175 2.2× 19 481
Yasuo Kodera Japan 8 120 0.8× 167 1.2× 40 0.4× 15 0.1× 167 2.1× 14 405
Eugenio Fiorentino Italy 15 156 1.0× 209 1.5× 63 0.6× 24 0.2× 149 1.8× 41 572
Yoshito Komatsu Japan 11 264 1.7× 98 0.7× 271 2.5× 18 0.2× 66 0.8× 24 422

Countries citing papers authored by David Reynoso

Since Specialization
Citations

This map shows the geographic impact of David Reynoso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Reynoso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Reynoso more than expected).

Fields of papers citing papers by David Reynoso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Reynoso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Reynoso. The network helps show where David Reynoso may publish in the future.

Co-authorship network of co-authors of David Reynoso

This figure shows the co-authorship network connecting the top 25 collaborators of David Reynoso. A scholar is included among the top collaborators of David Reynoso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Reynoso. David Reynoso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Dumont, Sarah, Dan Yang, Agathe Dumont, et al.. (2014). Targeted polytherapy in small cell sarcoma and its association with doxorubicin. Molecular Oncology. 8(8). 1458–1468. 13 indexed citations
2.
Dumont, Amaury G., Yanwen Yang, David Reynoso, et al.. (2012). Anti-tumor effects of the Notch pathway in gastrointestinal stromal tumors. Carcinogenesis. 33(9). 1674–1683. 17 indexed citations
3.
Reynoso, David. (2012). BIM MEDIATES IMATINIB-INDUCED APOPTOSIS OF GASTROINTESTINAL STROMAL TUMORS: TRANSLATIONAL IMPLICATIONS. Digital Commons-TMC (Texas Medical Center).
4.
Xie, Xianbiao, Markus P. Ghadimi, Eric D. Young, et al.. (2011). Combining EGFR and mTOR Blockade for the Treatment of Epithelioid Sarcoma. Clinical Cancer Research. 17(18). 5901–5912. 34 indexed citations
5.
Reynoso, David, Laura K. Nolden, Dan Yang, et al.. (2010). Synergistic induction of apoptosis by the Bcl‐2 inhibitor ABT‐737 and imatinib mesylate in gastrointestinal stromal tumor cells. Molecular Oncology. 5(1). 93–104. 23 indexed citations
6.
Wang, Wei‐Lien, Anthony P. Conley, David Reynoso, et al.. (2010). Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor. Cancer Chemotherapy and Pharmacology. 67(S1). 15–24. 62 indexed citations
7.
Reynoso, David, Vivek Subbiah, Jonathan C. Trent, et al.. (2010). Neoadjuvant treatment of soft‐tissue sarcoma: A multimodality approach. Journal of Surgical Oncology. 101(4). 327–333. 24 indexed citations
8.
Gupta, Anu, Srirupa Roy, Alexander J. Lazar, et al.. (2010). Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST). Proceedings of the National Academy of Sciences. 107(32). 14333–14338. 180 indexed citations
9.
Reynoso, David & Jonathan C. Trent. (2010). Neoadjuvant and adjuvant imatinib treatment in gastrointestinal stromal tumor: current status and recent developments. Current Opinion in Oncology. 22(4). 330–335. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026